Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank71
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-87.98M
Near historical average
Percentile
P71
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-82.09M
Historical baseline
PeriodValueYoY Change
2025$-87.98M+1.3%
2024$-89.15M-1.2%
2023$-88.13M+9.7%
2022$-97.58M+24.0%
2021$-128.32M-31.2%
2020$-97.83M-81.0%
2019$-54.04M-295.6%
2018$-13.66M-